Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Multiple myeloma (MM) remains a challenge in oncology despite progress in conventional treatments and high dose chemotherapy. This second volume from Springer addresses the need for new, biologically-based treatment approaches to overcome resistance and improve patient outcomes. This text focuses on current translational research aimed at developing molecularly-based combination therapies. These advancements hold the potential to achieve high frequency and durable responses for a majority of patients. By looking at recent breakthroughs in genomics and proteomics, the book provides a deep look into the science driving modern MM research. Designed for medical professionals and researchers, this volume explores the transition from laboratory discovery to clinical application. It covers the latest developments in the field to help professionals stay informed about the evolving landscape of multiple myeloma therapy and the science behind new treatment strategies.